Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$849M Sell
2,345,865
-70,534
-3% -$24.1M 0.2% 88
2026
Q1
$850M Buy
2,416,399
+450,496
+23% +$161M 0.23% 80
2025
Q4
$643M Sell
1,965,903
-86,287
-4% -$27.4M 0.17% 108
2025
Q3
$579M Sell
2,052,190
-66,697
-3% -$19.3M 0.15% 120
2025
Q2
$592M Sell
2,118,887
-92,211
-4% -$26.1M 0.16% 112
2025
Q1
$689M Sell
2,211,098
-212,177
-9% -$62.7M 0.21% 87
2024
Q4
$632M Sell
2,423,275
-1,257,138
-34% -$373M 0.18% 98
2024
Q3
$1.19B Buy
3,680,413
+117,921
+3% +$38.6M 0.33% 52
2024
Q2
$1.11B Buy
3,562,492
+77,115
+2% +$22.7M 0.33% 54
2024
Q1
$991M Sell
3,485,377
-82,982
-2% -$24.3M 0.29% 65
2023
Q4
$1.03B Buy
3,568,359
+519,406
+17% +$142M 0.33% 61
2023
Q3
$819M Sell
3,048,953
-103,990
-3% -$26M 0.29% 76
2023
Q2
$700M Sell
3,152,943
-309,908
-9% -$71.9M 0.24% 87
2023
Q1
$837M Buy
3,462,851
+868,455
+33% +$213M 0.31% 71
2022
Q4
$681M Buy
2,594,396
+155,952
+6% +$41.8M 0.26% 92
2022
Q3
$550M Sell
2,438,444
-9,643
-0.4% -$2.34M 0.22% 98
2022
Q2
$596M Buy
2,448,087
+357,441
+17% +$87.6M 0.23% 96
2022
Q1
$494M Buy
2,090,646
+30,422
+1% +$6.99M 0.16% 127
2021
Q4
$463M Sell
2,060,224
-180,238
-8% -$38M 0.14% 143
2021
Q3
$476M Sell
2,240,462
-729,339
-25% -$168M 0.15% 136
2021
Q2
$724M Sell
2,969,801
-366,359
-11% -$90.1M 0.22% 100
2021
Q1
$830M Sell
3,336,160
-438,848
-12% -$105M 0.26% 74
2020
Q4
$868M Sell
3,775,008
-222,334
-6% -$51.3M 0.29% 67
2020
Q3
$1.02B Buy
3,997,342
+95,701
+2% +$23.7M 0.39% 53
2020
Q2
$920M Buy
3,901,641
+166,076
+4% +$37.9M 0.37% 58
2020
Q1
$757M Sell
3,735,565
-465,451
-11% -$102M 0.37% 59
2019
Q4
$1.01B Sell
4,201,016
-1,283,534
-23% -$283M 0.38% 51
2019
Q3
$1.06B Buy
5,484,550
+541,743
+11% +$104M 0.43% 45
2019
Q2
$911M Buy
4,942,807
+4,598,329
+1,335% +$823M 0.36% 51
2019
Q1
$65.4M Buy
344,478
+22,572
+7% +$4.31M 0.35% 53
2018
Q4
$62.7M Sell
321,906
-43,251
-12% -$8.44M 0.4% 41
2018
Q3
$75.7M Buy
365,157
+31,912
+10% +$6.29M 0.4% 43
2018
Q2
$924K Sell
333,245
-36,748
-10% -$6.5M 0.01% 751
2018
Q1
$63.1M Sell
369,993
-11,135
-3% -$2.04M 0.41% 45
2017
Q4
$66.3M Buy
381,128
+24,953
+7% +$4.42M 0.42% 45
2017
Q3
$66.4M Sell
356,175
-42,861
-11% -$7.59M 0.43% 44
2017
Q2
$68.7M Sell
399,036
-23,709
-6% -$3.86M 0.44% 42
2017
Q1
$69.4M Sell
422,745
-81,384
-16% -$13.5M 0.41% 47
2016
Q4
$73.7M Buy
504,129
+79,147
+19% +$11.9M 0.37% 57
2016
Q3
$70.9M Sell
424,982
-22,114
-5% -$3.74M 0.41% 51
2016
Q2
$68M Sell
447,096
-25,158
-5% -$3.91M 0.42% 52
2016
Q1
$70.8K Buy
472,254
+1,126
+0.2% +$167K 0.37% 43
2015
Q4
$76.5K Sell
471,128
-18,457
-4% -$2.9M 0.39% 39
2015
Q3
$67.7K Buy
489,585
+3,854
+0.8% +$607K 0.38% 41
2015
Q2
$74.6K Buy
485,731
+33,388
+7% +$5.35M 0.4% 41
2015
Q1
$72.3M Buy
452,343
+74,367
+20% +$11.7M 0.4% 46
2014
Q4
$60.2M Buy
377,976
+107,388
+40% +$16.7M 0.34% 60
2014
Q3
$38M Sell
270,588
-58,717
-18% -$7.67M 0.23% 87
2014
Q2
$39M Buy
329,305
+212,301
+181% +$24.6M 0.24% 89
2014
Q1
$14.4M Buy
117,004
+12,031
+11% +$1.46M 0.09% 291
2013
Q4
$12M Buy
104,973
+89
+0.1% +$10.1K 0.08% 316
2013
Q3
$11.7M Buy
104,884
+12,866
+14% +$1.4M 0.08% 323
2013
Q2
$9.08M Buy
+92,018
New +$9.55M 0.06% 368

Other funds holding AMGN

Nuveen's AMGN Position: Q2 2026 in Review

Nuveen reduced its Amgen (AMGN) stake by 2.9% in Q2 2026, selling an estimated $24.1M and leaving 2,345,865 shares worth $849M. The position accounts for 0.2% of the portfolio, ranked #88.

Nuveen first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.19B in Q3 2024. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nuveen held 2,345,865 shares of Amgen worth $849M as of Q2 2026.
  • Nuveen sold 70,534 Amgen shares in Q2 2026, an estimated $24.1M.
  • Amgen made up 0.2% of Nuveen's portfolio in Q2 2026, its #88 holding.
  • Nuveen first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's Amgen position peaked at $1.19B in Q3 2024.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.